多重用药与运动认知风险综合征的关联
该横断面研究基于社区健康与退休研究队列,纳入1119名65岁及以上老年人,比较多重用药(规律使用≥5种药物)与运动认知风险综合征(MCR,表现为认知主诉和步速减慢)的流行病学关联。结果显示,多重用药者MCR患病率为10%,无多重用药者为6%;
要点
- 多重用药者MCR患病率为10%,无多重用药者为6%。
- 多重用药可能是痴呆的潜在可干预风险因素。
核心结论
- 在社区老年人中,多重用药与运动认知风险综合征(MCR)存在关联,提示多重用药可能是痴呆的潜在可改变风险因素。
研究设计与样本
- 横断面研究,基于社区健康与退休研究队列,纳入1119名65岁及以上成年人(平均年龄74.7±7.0岁,女性占59%)。
主要发现
- 417名多重用药者中MCR患病率为10%,702名无多重用药者中为6%。
关键数值与推荐
- 多重用药定义为规律使用5种或以上药物。
- MCR定义为无痴呆个体存在认知主诉和步速减慢。
临床怎么用
- 在老年医学科评估中,对多重用药患者应关注步速和认知主诉,警惕MCR可能。
- 多重用药作为潜在可干预因素,或可作为痴呆预防的干预靶点。
局限性
- 横断面设计无法推断因果关系。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Risk factors for motoric cognitive risk syndrome (MCR), a predementia syndrome characterized by slow gait and cognitive complaints, have been identified, but few are reversible. Polypharmacy is a potentially reversible risk factor for cognitive decline, but the relationship between MCR and polypharmacy has not been examined. Our aim was to compare the epidemiology of MCR and polypharmacy. DESIGN: Cross-sectional. SETTING: Community-based Health and Retirement Study cohort. PARTICIPANTS: A total of 1119 adults 65 years and older (mean age = 74.7 ± 7.0 y; 59% female). MEASUREMENTS: Polypharmacy is defined as the use of five or more regularly scheduled medications. MCR is defined as cognitive complaints and slow gait in an individual without dementia. RESULTS: The prevalence of MCR among 417 participants with polypharmacy was 10%; it was 6% among 702 participants without polypharmacy. The odds of meeting MCR criteria in those with polypharmacy was 1.8 (confidence interval = 1.0-3.0; P = .035) compared with those without polypharmacy, even after adjusting for high-risk medication use. CONCLUSION: Our results show the coexistence of MCR and polypharmacy in older adults, suggesting a potentially modifiable risk factor for dementia. J Am Geriatr Soc 68:1072-1077, 2020.
引用
- George CJ, Verghese J. Motoric Cognitive Risk Syndrome in Polypharmacy. J Am Geriatr Soc. 2020. PMID: 32092166. doi:10.1111/jgs.16380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。